Targeting CDK7 reverses tamoxifen resistance through regulating stemness in ER+ breast cancer

被引：0
作者：
Yasmin M. Attia
Salama A. Salama
Samia A. Shouman
Cristina Ivan
Abdelrahman M. Elsayed
Paola Amero
Cristian Rodriguez-Aguayo
Gabriel Lopez-Berestein
机构：
[1] Cairo University,Pharmacology and Experimental Therapeutics Unit, Cancer Biology Department, National Cancer Institute
[2] Al-Azhar University,Pharmacology and Toxicology Department, Faculty of Pharmacy
[3] The University of Texas MD Anderson Cancer Center,Department of Experimental Therapeutics
[4] The University of Texas MD Anderson Cancer Center,Center for RNA Interference and Non
[5] The University of Texas MD Anderson Cancer Center,Coding RNA
来源：
Pharmacological Reports | 2022年 / 74卷
关键词：
Breast cancer; Cancer stem cells; Tamoxifen; Cyclin-dependent kinase; SOX2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：366 / 378
页数：12
相关论文
共 50 条
  • [41] Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer
    Maryam Soleimani Dodaran
    Simone Borgoni
    Emre Sofyalı
    Pernette J. Verschure
    Stefan Wiemann
    Perry D. Moerland
    Antoine H. C. van Kampen
    BMC Cancer, 20
  • [42] Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2-breast cancer
    Dodaran, Maryam Soleimani
    Borgoni, Simone
    Sofyali, Emre
    Verschure, Pernette J.
    Wiemann, Stefan
    Moerland, Perry D.
    van Kampen, Antoine H. C.
    BMC CANCER, 2020, 20 (01)
  • [43] Defining the transcriptional and biological response to CDK4/6 inhibition in relation to ER+/HER2-breast cancer
    Knudsen, Erik S.
    Witkiewicz, Agnieszka K.
    ONCOTARGET, 2016, 7 (43) : 69111 - 69123
  • [44] Biomarkers of Response and Resistance to Palbociclib Plus Letrozole in Patients With ER+/HER2- Breast Cancer
    Dowsett, Mitch
    Kilburn, Lucy
    Rimawi, Mothaffar F.
    Osborne, C. Kent
    Pogue-Geile, Katherine
    Liu, Yuan
    Jacobs, Samuel A.
    Finnigan, Melanie
    Puhalla, Shannon
    Dodson, Andrew
    Martins, Vera
    Cheang, Maggie
    Perry, Sophie
    Holcombe, Chris
    Turner, Nick
    Swift, Claire
    Bliss, Judith M.
    Johnston, Stephen
    CLINICAL CANCER RESEARCH, 2022, 28 (01) : 163 - 174
  • [45] USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα
    Zhuang, Ting
    Zhang, Shuqing
    Liu, Dongyi
    Li, Zhongbo
    Li, Xin
    Li, Jiaoyan
    Yang, Penghe
    Zhang, Chenmiao
    Cui, Jiayao
    Fu, Mingxi
    Shen, Fangyu
    Yuan, Lei
    Zhang, Zhao
    Su, Peng
    Zhu, Jian
    Yang, Huijie
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [46] Reversal of tamoxifen resistance by artemisinin in ER plus breast cancer: bioinformatics analysis and experimental validation
    Zhuo, Zhili
    Zhang, Dongni
    Lu, Wenping
    Wu, Xiaoqing
    Cui, Yongjia
    Zhang, Weixuan
    Zhang, Mengfan
    ONCOLOGY RESEARCH, 2024, 32 (06) : 1093 - 1107
  • [47] Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer
    Goekmen-Polar, Yesim
    Toroni, Rachel A.
    Hocevar, Barbara A.
    Badve, Sunil
    Zhao, Qianqian
    Shen, Changyu
    Bruckheimer, Elizabeth
    Kinch, Michael S.
    Miller, Kathy D.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (02) : 375 - 384
  • [48] Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer
    Yesim Gökmen-Polar
    Rachel A. Toroni
    Barbara A. Hocevar
    Sunil Badve
    Qianqian Zhao
    Changyu Shen
    Elizabeth Bruckheimer
    Michael S. Kinch
    Kathy D. Miller
    Breast Cancer Research and Treatment, 2011, 127 : 375 - 384
  • [49] Overcoming CDK4/6 inhibitor resistance in ER-positive breast cancer
    Portman, Neil
    Alexandrou, Sarah
    Carson, Emma
    Wang, Shudong
    Lim, Elgene
    Caldon, C. Elizabeth
    ENDOCRINE-RELATED CANCER, 2019, 26 (01) : R15 - R30
  • [50] Tamoxifen modulates nutrition deprivation-induced ER stress through AMPK-mediated ER-phagy in breast cancer cells
    Bidisha, Biswas
    Sowmya, Manickavasagan
    Shalini, Suchita
    Mythri, Chandrasekaran
    Gupta, Anshu
    Vijayakumar, Gangipangi
    Sudhagar, Selvaraju
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 207 (03) : 649 - 663
12345